These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27174504)

  • 61. A multi-state Markov model using notification data to estimate HIV incidence, number of undiagnosed individuals living with HIV, and delay between infection and diagnosis: Illustration in France, 2008-2018.
    Castel C; Sommen C; Strat YL; Alioum A
    Stat Methods Med Res; 2021 Nov; 30(11):2382-2398. PubMed ID: 34606379
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Progress in the HIV epidemic: Identifying goals and measuring success.
    Jones J; Sullivan PS; Curran JW
    PLoS Med; 2019 Jan; 16(1):e1002729. PubMed ID: 30657770
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Changing Knowledge and Attitudes Towards HIV Treatment-as-Prevention and "Undetectable = Untransmittable": A Systematic Review.
    Bor J; Fischer C; Modi M; Richman B; Kinker C; King R; Calabrese SK; Mokhele I; Sineke T; Zuma T; Rosen S; Bärnighausen T; Mayer KH; Onoya D
    AIDS Behav; 2021 Dec; 25(12):4209-4224. PubMed ID: 34036459
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Multisectoral (in)action: towards effective mainstreaming of HIV in public sector departments in South Africa.
    Mahlangu P; Vearey J; Goudge J
    Afr J AIDS Res; 2018 Dec; 17(4):301-312. PubMed ID: 30466345
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Defining control of HIV epidemics.
    Galvani AP; Pandey A; Fitzpatrick MC; Medlock J; Gray GE
    Lancet HIV; 2018 Nov; 5(11):e667-e670. PubMed ID: 30314745
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Getting more from heterogeneous HIV-1 surveillance data in a high immigration country: estimation of incidence and undiagnosed population size using multiple biomarkers.
    Giardina F; Romero-Severson EO; Axelsson M; Svedhem V; Leitner T; Britton T; Albert J
    Int J Epidemiol; 2019 Dec; 48(6):1795-1803. PubMed ID: 31074780
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Is total community viral load a robust predictive marker of the efficacy of the TasP strategy?
    Henard S; Jeanmaire E; Nguyen Y; Yazdanpanah Y; Cheret A; Hoen B; Rey D; Borel A; Chavanet P; May T; Rabaud C;
    J Acquir Immune Defic Syndr; 2012 Nov; 61(3):400-2. PubMed ID: 22732466
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The emerging HIV epidemic among men who have sex with men in Taiwan.
    Huang YF; Chen CH; Chang FY
    J Formos Med Assoc; 2013 Jul; 112(7):369-71. PubMed ID: 23927976
    [No Abstract]   [Full Text] [Related]  

  • 69. A New Method for Estimating the Incidence of Infectious Diseases.
    McManus H; Callander D; Asselin J; McMahon J; Hoy JF; Templeton DJ; Fairley CK; Donovan B; Pedrana AE; Keen P; Wilson DP; Elliott J; Kaldor J; Liaw ST; Petoumenos K; Holt M; Hellard ME; Grulich AE; Carr A; Stoove MA; Guy RJ
    Am J Epidemiol; 2021 Jul; 190(7):1386-1395. PubMed ID: 33534904
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Optimizing Human Immunodeficiency Virus Testing Interventions for Men Who Have Sex With Men in the United States: A Modeling Study.
    Delaney KP; Rosenberg ES; Kramer MR; Waller LA; Sullivan PS
    Open Forum Infect Dis; 2015 Dec; 2(4):ofv153. PubMed ID: 26613096
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Special report: youth & HIV risk. Minority MSM population key part of growing epidemic in teens. New biomedical prevention is needed.
    AIDS Alert; 2010 Aug; 25(8):85-8. PubMed ID: 27027109
    [No Abstract]   [Full Text] [Related]  

  • 72. Dynamics of the HIV epidemic in MSM.
    Jia Y; Aliyu MH; Jennifer Huang Z
    Biomed Res Int; 2014; 2014():497543. PubMed ID: 25093171
    [No Abstract]   [Full Text] [Related]  

  • 73. HIV General Population Surveys: Shedding Light on the Status of HIV Epidemics and Informing Future Actions.
    Porter L; Bello G; Nkambule R; Justman J
    J Acquir Immune Defic Syndr; 2021 Aug; 87(Suppl 1):S2-S5. PubMed ID: 34166307
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Assessing the reliability of the CD4 depletion model in the presence of Ending the HIV Epidemic initiatives.
    Tang ME; Goyal R; Anderson CM; Mehta SR; Little SJ
    AIDS; 2023 Aug; 37(10):1617-1624. PubMed ID: 37260256
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bayesian back-calculation using a multi-state model with application to HIV.
    Sweeting MJ; De Angelis D; Aalen OO
    Stat Med; 2005 Dec; 24(24):3991-4007. PubMed ID: 16320278
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Estimating the First 90 of the UNAIDS 90-90-90 Goal: A Review.
    Sohail M; Levitan EB; Rana AI; Heath SL; Rastegar J; Kempf MC; Long DM
    J Int Assoc Provid AIDS Care; 2020; 19():2325958220919290. PubMed ID: 32351155
    [TBL] [Abstract][Full Text] [Related]  

  • 77. HIV: The Hidden Epidemic.
    Brady V
    J Assoc Nurses AIDS Care; 2023 Nov-Dec 01; 34(6):501. PubMed ID: 37738523
    [No Abstract]   [Full Text] [Related]  

  • 78. No increase in HIV incidence in a cohort of men who have sex with men in Montréal: too early to conclude?
    Boily MC; Bastos FI; Mâsse B
    AIDS; 2002 Dec; 16(18):2502-3. PubMed ID: 12461434
    [No Abstract]   [Full Text] [Related]  

  • 79. More and better information to tackle HIV epidemics: towards improved HIV incidence assays.
    Incidence Assay Critical Path Working Group
    PLoS Med; 2011 Jun; 8(6):e1001045. PubMed ID: 21731474
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ending the Human Immunodeficiency Virus Epidemic: Towards an Evidence-Based Approach.
    Fojo AT; Dowdy DW
    Clin Infect Dis; 2019 Nov; 69(12):2199-2200. PubMed ID: 31609445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.